Multicompartmental Pharmacokinetic Model of Tenofovir Delivery to the Rectal Mucosa by an Enema
Authors:
Open Access
- 23 January 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (1) , e0167696
Abstract
Rectal enemas that contain prophylactic levels of anti-HIV microbicides such as tenofovir have emerged as a promising dosage form to prevent sexually transmitted HIV infections. The enema vehicle is promising due to its likely ability to deliver a large amount of drug along the length of the rectal canal. Computational models of microbicide drug delivery by enemas can help their design process by determining key factors governing drug transport and, more specifically, the time history and degree of protection. They can also inform interpretations of experimental pharmacokinetic measures such as drug concentrations in biopsies. The present work begins rectal microbicide PK modeling, for enema vehicles. Results here show that a paramount factor in drug transport is the time of enema retention; direct connectivity between enema fluid and the fluid within rectal crypts is also important. Computations of the percentage of stromal volume protected by a single enema dose indicate that even with only a minute of enema retention, protection of 100% can be achieved after around 14 minutes post dose. Concentrations in biopsies are dependent on biopsy thickness; and control and/or knowledge of thickness could improve accuracy and decrease variability in biopsy measurements. Results here provide evidence that enemas are a promising dosage form for rectal microbicide delivery, and offer insights into their rational design.Keywords
Funding Information
- National Institutes of Health (RO1 HD 072702)
- National Institutes of Health (U19 AI 077289)
This publication has 34 references indexed in Scilit:
- Multicompartmental Pharmacokinetic Model of Tenofovir Delivery by a Vaginal GelPLOS ONE, 2013
- Drug-Eluting Fibers for HIV-1 Inhibition and ContraceptionPLOS ONE, 2012
- Morphology of the epithelium of the lower rectum and the anal canal in the adult humanMedical Molecular Morphology, 2012
- Reformulated tenofovir gel for use as a dual compartment microbicideJournal of Antimicrobial Chemotherapy, 2012
- Development of a Combination Microbicide Gel Formulation Containing IQP-0528 and Tenofovir for the Prevention of HIV InfectionJournal of Pharmaceutical Sciences, 2012
- Compartmental Transport Model of Microbicide Delivery by an Intravaginal RingJournal of Pharmaceutical Sciences, 2010
- In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 MicrobicidePLOS ONE, 2010
- Topical Microbicides to Prevent HIV: Clinical Drug Development ChallengesAnnual Review of Pharmacology and Toxicology, 2009
- Tenofovir Disoproxil FumarateClinical Pharmacokinetics, 2004
- The length of the anal canalDiseases of the Colon & Rectum, 1981